FDA Focus: What King & Spalding's Practice Head Is Watching
In Law360's latest installment of FDA Focus, King & Spalding's longtime U.S. Food and Drug Administration practice leader discusses how plaintiffs lawyers are capitalizing on warning letters, how regulators may strike...To view the full article, register now.
Already a subscriber? Click here to view full article